4.7 Review

Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer

Shiro Kohi et al.

Summary: This study investigated the microbiome profiles of duodenal fluid in patients with pancreas ductal adenocarcinoma (PDAC), pancreatic cyst(s), and normal pancreata. The findings suggest that PDAC patients have alterations in their duodenal fluid microbiomes compared to patients with pancreatic cysts and normal pancreata.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Oncology

Emerging applications of bacteria as antitumor agents

Vipin Chandra Kalia et al.

Summary: Bacteria associated with the human body can survive in tumors and produce substances that can kill tumor cells, making them potential anticancer agents.

SEMINARS IN CANCER BIOLOGY (2022)

Article Oncology

A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma

Gouri Pandya et al.

Summary: Pancreatic carcinoma is a highly aggressive and drug-resistant cancer, and studies have shown that the oral, gut, and tumor microbiota play a critical role in its development. The microbiota has the unique ability to influence the tumor microenvironment and the metabolism of chemotherapeutic agents, making it an important area of research.

SEMINARS IN CANCER BIOLOGY (2022)

Article Biology

Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer

Wei Guo et al.

Summary: Guo, Zhang, Guo et al. analyzed microbiome alterations in different molecular subtypes of PDAC and found distinct signatures in basal-like tumors, characterized by an increase in certain bacteria, such as Acinetobacter, Pseudomonas, and Sphingopyxis. They associated the increased abundance of these bacteria with heightened inflammation and carcinogenic potential, as indicated by pathway analyses.

COMMUNICATIONS BIOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors

Sama Rezasoltani et al.

Summary: The gut microbiota plays a dual role in triggering GI cancers, its association with host immunity, and its beneficial functions in modulating cancer immunotherapy responses.

CANCER MEDICINE (2021)

Article Oncology

European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer

G. Carioli et al.

Summary: The research predicts a continued decline in cancer mortality in the EU in 2021, with an increase in female lung cancer rates. Pancreatic cancer, breast cancer, and some other cancers are expected to decrease, but attention is needed on pancreatic cancer, which shows significant declines in young men.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Immunotherapy for pancreatic ductal adenocarcinoma

Eileen Carpenter et al.

Summary: This review explores the molecular components responsible for the immune-privileged state in pancreatic ductal adenocarcinoma (PDAC) and provides an overview of immunotherapeutic strategies for PDAC, including vaccine therapy, checkpoint blockade, myeloid-targeted therapy, and immune agonist therapy.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Review Pharmacology & Pharmacy

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis

Pinyi Liu et al.

Summary: Short-chain fatty acids (SCFAs), produced during bacterial fermentation of dietary fiber, play crucial roles in regulating inflammation, carcinogenesis, intestinal barrier function, and oxidative stress. Their signaling mechanisms involve histone acetylation promotion and activation of G-protein-coupled receptors. SCFAs have a wide range of positive effects and show high therapeutic potential in human-related diseases.

PHARMACOLOGICAL RESEARCH (2021)

Review Gastroenterology & Hepatology

Microbiome and pancreatic ductal adenocarcinoma

Annemilai Tijeras-Raballand et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a tumor with poor prognosis, and its incidence and related deaths are increasing. Bacteria and fungi in the tumor microenvironment play important roles in the development and treatment of PDAC.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors

Virinder Sarhadi et al.

Summary: Higher Enterobacteriaceae abundance is associated with all types of gastric tumors, suggesting it could potentially be a useful marker for gastric malignancies. Lower gut microbiota diversity may indicate poorly differentiated, invasive, advanced or aggressive tumors, and could serve as a prognostic marker for gastric tumors.

GUT PATHOGENS (2021)

Review Microbiology

Outer Membrane Vesicles of Gram-Negative Bacteria: An Outlook on Biogenesis

Eric Daniel Avila-Calderon et al.

Summary: OMVs from Gram-negative bacteria were first described over 50 years ago, but the molecular mechanisms involved in their biogenesis have only been studied in recent decades. The current knowledge of OMV biogenesis and release mechanisms is incomplete, with recent studies focusing on various cellular components.

FRONTIERS IN MICROBIOLOGY (2021)

Review Oncology

Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut

Qin Yu et al.

Summary: Evidence shows an emerging association between microbes and pancreatic cancer in terms of risk, development, treatment response, and post-treatment survivorship. Understanding the role of the microbiome helps to reveal the natural history of pancreatic cancer.

NEOPLASIA (2021)

Review Oncology

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind

Tatjana Arsenijevic et al.

Summary: Microbiota on oral, gut, and intratumoral regions have significant impacts on the development, progression, and chemoresistance of pancreatic ductal adenocarcinoma, potentially serving as diagnostic, prognostic, and predictive biomarkers for this aggressive cancer.

CANCERS (2021)

Review Gastroenterology & Hepatology

Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

Alison P. Klein

Summary: Pancreatic cancer is a leading cause of cancer death globally, with significant risk factors including smoking, obesity, diabetes, and genetic factors. Efforts to understand and address these modifiable and inherited risk factors are crucial for early detection and prevention strategies for pancreatic cancer.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Oncology

Microbiome and colorectal cancer: A review of the past, present, and future

Michael S. Johns et al.

Summary: The human gastrointestinal tract harbors a diverse range of microorganisms, collectively known as the microbiome, which play a crucial role in regulating human health. Changes in the microbiome have been linked to various diseases such as obesity, inflammatory bowel disease, and cancer. Recent research has focused on understanding the impact of the microbiome on human immunity, nutrient absorption, digestion, and metabolism.

SURGICAL ONCOLOGY-OXFORD (2021)

Review Oncology

Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis

Lumir Kunovsky et al.

Summary: H. pylori infection is associated with various diseases such as gastrointestinal diseases, neurological disorders, and skin diseases. However, its relationship with pancreatic diseases, especially pancreatic adenocarcinoma and autoimmune forms of chronic pancreatitis, is not well understood. Research is ongoing to explore this potential connection further.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Microbiota in pancreatic health and disease: the next frontier in microbiome research

Ryan M. Thomas et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Multidisciplinary Sciences

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

Deborah Nejman et al.

SCIENCE (2020)

Review Surgery

Pancreatic cancer treatment: better, but a long way to go

Robert J. Torphy et al.

SURGERY TODAY (2020)

Review Oncology

Immunotherapy for pancreatic cancer: A 2020 update

Dimitrios Schizas et al.

CANCER TREATMENT REVIEWS (2020)

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

Article Multidisciplinary Sciences

The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic

Eliran Kadosh et al.

NATURE (2020)

Review Multidisciplinary Sciences

Host-microbiota maladaptation in colorectal cancer

Alina Janney et al.

NATURE (2020)

Review Oncology

Microbiome Dysbiosis and Predominant Bacterial Species as Human Cancer Biomarkers

Mohsen Sagheb R. Shirazi et al.

JOURNAL OF GASTROINTESTINAL CANCER (2020)

Review Oncology

Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy

Xiang Zhang et al.

JOURNAL OF CANCER (2020)

Article Gastroenterology & Hepatology

The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy

Vrishketan Sethi et al.

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer

Rogier Aaron Gaiser et al.

Review Nutrition & Dietetics

Pancreas-Microbiota Cross Talk in Health and Disease

Timon E. Adolph et al.

ANNUAL REVIEW OF NUTRITION, VOL 39, 2019 (2019)

Review Biochemistry & Molecular Biology

Chemoresistance in Pancreatic Cancer

Siyuan Zeng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL

Berk Aykut et al.

NATURE (2019)

Article Multidisciplinary Sciences

Fecal microbiome signatures of pancreatic cancer patients

Elizabeth Half et al.

SCIENTIFIC REPORTS (2019)

Article Nutrition & Dietetics

Polyamines and Gut Microbiota

Rosanna Tofalo et al.

FRONTIERS IN NUTRITION (2019)

Article Oncology

The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Vancheswaran Gopalakrishnan et al.

CANCER CELL (2018)

Article Gastroenterology & Hepatology

Stool Microbiota Composition Differs in Patients with Stomach, Colon, and Rectal Neoplasms

Omar Youssef et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Editorial Material Oncology

Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling

Erick Riquelme et al.

CANCER DISCOVERY (2018)

Review Multidisciplinary Sciences

Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism

Amaia Arruabarrena-Aristorena et al.

SCIENCE ADVANCES (2018)

Article Oncology

Elevated Polyamines in Saliva of Pancreatic Cancer

Yasutsugu Asai et al.

CANCERS (2018)

Article Biochemistry & Molecular Biology

Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer

Tomohiro Maekawa et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Oncology

Polyamine metabolism and cancer: treatments, challenges and opportunities

Robert A. Casero et al.

NATURE REVIEWS CANCER (2018)

Review Oncology

Early detection of pancreatic cancer: Where are we now and where are we going?

Bin Zhou et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Article Microbiology

Pancreatic cyst fluid harbors a unique microbiome

Shan Li et al.

MICROBIOME (2017)

Article Oncology

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Andrew J. Aguirre et al.

CANCER CELL (2017)

Review Gastroenterology & Hepatology

Periodontal Pathogens in the Etiology of Pancreatic Cancer

Mesut Ogrendik

GASTROINTESTINAL TUMORS (2017)

Review Oncology

Pancreatic cancer: yesterday, today and tomorrow

Daniel Ansari et al.

FUTURE ONCOLOGY (2016)

Article Oncology

Helicobacter pylori infection and pancreatic cancer risk: A meta-analysis

Yu Guo et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)

Article Biotechnology & Applied Microbiology

Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells

JaeJin An et al.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2016)

Article Multidisciplinary Sciences

Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome

Rachel J. Perry et al.

NATURE (2016)

Article Multidisciplinary Sciences

Characterization of the salivary microbiome in patients with pancreatic cancer

Pedro J. Torres et al.

PEERJ (2015)

Article Oncology

Clinical, Laboratory Biomarkers and Imaging Findings of Pancreatic Adenocarcinoma in Iran

Mohammad Hadizadeh et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Article Biochemistry & Molecular Biology

Oncogenic K-Ras requires activation for enhanced activity

H. Huang et al.

ONCOGENE (2014)

Review Public, Environmental & Occupational Health

Infection and Cancer: Global Distribution and Burden of Diseases

Jin-Kyoung Oh et al.

ANNALS OF GLOBAL HEALTH (2014)

Review Oncology

Role of bacterial infections in pancreatic cancer

Dominique S. Michaud

CARCINOGENESIS (2013)

Review Oncology

Inherited Pancreatic Cancer Syndromes

Sheila Solomon et al.

CANCER JOURNAL (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Gastroenterology & Hepatology

History of Peptic Ulcer Disease and Pancreatic Cancer Risk in Men

Ying Bao et al.

GASTROENTEROLOGY (2010)

Article Oncology

Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras

Sharon Y. Gidekel Friedlander et al.

CANCER CELL (2009)

Article Gastroenterology & Hepatology

Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients

Hans-Olof Nilsson et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2006)

Article Nutrition & Dietetics

Tooth loss, pancreatic cancer, and Helicobacter pylori

RZ Stolzenberg-Solomon et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)

Article Oncology

Helicobacter pylori seropositivity as a risk factor for pancreatic cancer

RZ Stolzenberg-Solomon et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.